Save your place

Sign in to WhoBought

Please try again later.

Alaunos Therapeutics, Inc. (TCRT) institutional ownership

Market cap$7.7M SectorHealthcare
Funds holding · Q3 2024
47
reported TCRT position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q3 2024
Activity unavailable N/A
0 buyers · 47 sellers

Alaunos Therapeutics, Inc. (TCRT) price and institutional activity

Dates

Q3 2024

$0 bought by 0 investors
$0 sold by 47 investors
Msd Partners, L.P.Vanguard +45 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Alaunos Therapeutics, Inc. (TCRT) institutional activity · 47

Investor Type Est. change Change Δ Own Date
Msd Partners, L.P. · Exited
Change −1.0M Δ Own −100.0% Date Q3 2024
Msd Partners, L.P. Exited· Q3 2024 −1.0M −100.0% Q3 2024
Vanguard · Exited
Change −629K Δ Own −100.0% Date Q3 2024
Vanguard Exited· Q3 2024 −629K −100.0% Q3 2024
Geode · Exited
Change −164K Δ Own −100.0% Date Q3 2024
Geode Exited· Q3 2024 −164K −100.0% Q3 2024
UBS Group AG · Exited
Change −55K Δ Own −100.0% Date Q3 2024
UBS Group AG Exited· Q3 2024 −55K −100.0% Q3 2024
State Street · Exited
Change −50K Δ Own −100.0% Date Q3 2024
State Street Exited· Q3 2024 −50K −100.0% Q3 2024
Commerce Bank · Exited
Change −29K Δ Own −100.0% Date Q3 2024
Commerce Bank Exited· Q3 2024 −29K −100.0% Q3 2024
Northern Trust · Exited
Change −29K Δ Own −100.0% Date Q3 2024
Northern Trust Exited· Q3 2024 −29K −100.0% Q3 2024
Osaic Holdings, Inc. · Exited
Change −24K Δ Own −100.0% Date Q3 2024
Osaic Holdings, Inc. Exited· Q3 2024 −24K −100.0% Q3 2024
Magnolia Capital Advisors LLC · Exited
Change −21K Δ Own −100.0% Date Q3 2024
Magnolia Capital Advisors LLC Exited· Q3 2024 −21K −100.0% Q3 2024
Citadel Advisors LLC Exited· Q3 2024 −17K −100.0% Q3 2024
Allred Capital Management, LLC · Exited
Change −17K Δ Own −100.0% Date Q3 2024
Allred Capital Management, LLC Exited· Q3 2024 −17K −100.0% Q3 2024
Pfg Investments, LLC · Exited
Change −16K Δ Own −100.0% Date Q3 2024
Pfg Investments, LLC Exited· Q3 2024 −16K −100.0% Q3 2024
Morgan Stanley · Exited
Change −15K Δ Own −100.0% Date Q3 2024
Morgan Stanley Exited· Q3 2024 −15K −100.0% Q3 2024
CIBC Private Wealth Group LLC · Exited
Change −15K Δ Own −100.0% Date Q3 2024
CIBC Private Wealth Group LLC Exited· Q3 2024 −15K −100.0% Q3 2024
Fortis Group Advisors, LLC · Exited
Change −14K Δ Own −100.0% Date Q3 2024
Fortis Group Advisors, LLC Exited· Q3 2024 −14K −100.0% Q3 2024
Data through Q3 2024 · filed Dec 26, 2024
15 of 47

Famous investor activity in Alaunos Therapeutics, Inc. (TCRT)

Alaunos Therapeutics, Inc. (TCRT) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Weis Holger · Officer Grant (A) $9K
Price $2.26 Qty 4K Owned 17K ΔOwn +30.6% Trade date Jun 30, 2026 Filed date Jul 2, 2026
Weis Holger Officer Grant (A) $2.26 4K $9K 17K +30.6% Jun 30, 2026 Jul 2, 2026
Weis Holger · CEO Grant (A) $18K
Price $2.26 Qty 8K Owned 13K Trade date Jun 12, 2026 Filed date Jun 17, 2026
Weis Holger CEO Grant (A) $2.26 8K $18K 13K Jun 12, 2026 Jun 17, 2026
Weis Holger · CEO Grant (A) $9K
Price $2.37 Qty 4K Owned 5K Trade date May 22, 2026 Filed date May 27, 2026
Weis Holger CEO Grant (A) $2.37 4K $9K 5K May 22, 2026 May 27, 2026
Vieser Jaime · Director Grant (A) $17K
Price $2.59 Qty 7K Owned 39K Trade date Apr 29, 2026 Filed date May 1, 2026
Vieser Jaime Director Grant (A) $2.59 7K $17K 39K Apr 29, 2026 May 1, 2026
Postma Robert W. · Director Grant (A) $16K
Price $2.59 Qty 6K Owned 50K Trade date Apr 29, 2026 Filed date May 1, 2026
Postma Robert W. Director Grant (A) $2.59 6K $16K 50K Apr 29, 2026 May 1, 2026
Jerman Michael Allen · Director Grant (A) $16K
Price $2.59 Qty 6K Owned 16K Trade date Apr 29, 2026 Filed date May 1, 2026
Jerman Michael Allen Director Grant (A) $2.59 6K $16K 16K Apr 29, 2026 May 1, 2026
Jerman Michael Allen · Director Grant (A) $16K
Price $2.89 Qty 5K Owned 10K Trade date Jan 12, 2026 Filed date Jan 15, 2026
Jerman Michael Allen Director Grant (A) $2.89 5K $16K 10K Jan 12, 2026 Jan 15, 2026
Postma Robert W. · Director Grant (A) $16K
Price $2.89 Qty 6K Owned 44K Trade date Jan 12, 2026 Filed date Jan 15, 2026
Postma Robert W. Director Grant (A) $2.89 6K $16K 44K Jan 12, 2026 Jan 15, 2026
Vieser Jaime · Director Grant (A) $17K
Price $2.89 Qty 6K Owned 32K Trade date Jan 12, 2026 Filed date Jan 15, 2026
Vieser Jaime Director Grant (A) $2.89 6K $17K 32K Jan 12, 2026 Jan 15, 2026
Vieser Jaime · Director Grant (A) $17K
Price $3.16 Qty 5K Owned 26K Trade date Nov 21, 2025 Filed date Nov 26, 2025
Vieser Jaime Director Grant (A) $3.16 5K $17K 26K Nov 21, 2025 Nov 26, 2025
Postma Robert W. · Director Grant (A) $16K
Price $3.16 Qty 5K Owned 38K Trade date Nov 21, 2025 Filed date Nov 26, 2025
Postma Robert W. Director Grant (A) $3.16 5K $16K 38K Nov 21, 2025 Nov 26, 2025
Jerman Michael Allen · Director Grant (A) $13K
Price $3.16 Qty 4K Owned 4K Trade date Nov 21, 2025 Filed date Nov 26, 2025
Jerman Michael Allen Director Grant (A) $3.16 4K $13K 4K Nov 21, 2025 Nov 26, 2025
Groenewald Ferdinand · Officer 2 operations 15K
Owned 4K Trade date Aug 18, 2025 Filed date Aug 20, 2025
Groenewald Ferdinand Officer 2 operations 15K 4K Aug 18, 2025 Aug 20, 2025
Weis Holger · Director, Officer Grant (A) 14K
Owned 14K Trade date Aug 18, 2025 Filed date Aug 20, 2025
Weis Holger Director, Officer Grant (A) 14K 14K Aug 18, 2025 Aug 20, 2025
14 of 14

Alaunos Therapeutics, Inc. (TCRT) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Discovery Capital Management, LLC / Ct 13.3M
% of shares outstanding 6.2% Filing date Feb 14, 2022
Discovery Capital Management, LLC / Ct 13.3M 6.2% Feb 14, 2022
Vanguard Group Inc 11.6M
% of shares outstanding 5.4% Filing date Feb 10, 2022
Vanguard Group Inc 11.6M 5.4% Feb 10, 2022
Hardie Robert D. 10.3M
% of shares outstanding 4.8% Filing date Feb 11, 2022
Hardie Robert D. 10.3M 4.8% Feb 11, 2022
BlackRock Inc. 5.2M
% of shares outstanding 2.4% Filing date Jul 8, 2022
BlackRock Inc. 5.2M 2.4% Jul 8, 2022
Miller Value Partners, LLC 3.8M
% of shares outstanding 1.7% Filing date Oct 12, 2021
Miller Value Partners, LLC 3.8M 1.7% Oct 12, 2021
State Street Corp
% of shares outstanding 0.3% Filing date Jan 20, 2023
State Street Corp 0.3% Jan 20, 2023
Strategic Ep, LLC 0
% of shares outstanding 0.0% Filing date Oct 16, 2025
Strategic Ep, LLC 0 0.0% Oct 16, 2025
Msd Partners, L.P. 0
% of shares outstanding 0.0% Filing date Feb 13, 2025
Msd Partners, L.P. 0 0.0% Feb 13, 2025
8 of 8

Alaunos Therapeutics, Inc. (TCRT) ownership FAQ

Who owns TCRT?

47 reporting institutions disclosed TCRT position changes in the Q3 2024 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q3 2024.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.